Home › Ewing Sarcoma › New Jersey
Pag-aaral pangklinika para sa Ewing Sarcoma sa New Jersey
4 pag-aaral para sa Ewing Sarcoma ang naghahanap ng mga kalahok sa mga site sa New Jersey.
Opisyal na teksto ng pag-aaral (English)
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Rutgers Cancer Institute of New Jersey ( Site 1008), New Brunswick
Nagre-recruitPhase 1/2
6 Months – 25 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06395103Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Hackensack University Medical Center, Hackensack
Nagre-recruitPhase 1/2
Hanggang edad 30 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06541262Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Hackensack University Medical Center, Hackensack
Nagre-recruitPhase 1/2
Hanggang edad 26 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06465199Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
- Memorial Sloan Kettering at Basking Ridge (Consent and Follow Up), Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent and Followup), Middletown
Nagre-recruitObservasyonal na pag-aaral
Edad 4 pataas · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT03442465Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.